Analystreport

Innovate Biopharmaceuticals Inc (NASDAQ: INNT) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating.

INNOVATE BIOPHARMACEUTICALS  (INNT) 
Last innovate biopharmaceuticals earnings: 8/8 04:30 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.innovatebiopharma.com/news-releases